FUSN Market Cap History



Below is a table of the FUSN market cap history going back to 6/26/2020:

Date FUSN Market Cap
6/26/2020708.29M
8/4/2020567.88M
11/3/2020538.26M
3/15/2021497.12M
5/3/2021386.35M
8/3/2021354.48M
11/2/2021301.46M
3/7/2022303.32M
4/29/2022227.11M
7/29/2022101.10M
10/28/2022112.80M
5/2/2023241.98M
7/28/2023229.07M
10/27/2023291.80M
4/3/20241.81B

Also see: FUSN Shares Outstanding History
and FUSN YTD Return
FUSN Historical Market Cap:
+28.25% CAGR
FUSN Historical Market Cap: +28.25% CAGR

Mouse over chart for data details
6/26/2020 ...4/3/2024
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Co. has developed its Targeted Alpha Therapies, or TAT, platform together with its proprietary Fast-Clear linker technology to enable them to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Co. serves health care sectors in Canada. We show 15 historical shares outstanding datapoints in our FUSN shares outstanding history coverage, used to compute FUSN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing FUSN market cap history over the course of time is important for investors interested in comparing FUSN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of FUSN versus a peer is one thing; comparing FUSN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like FUSN can fluctuate over the course of history. With this page we aim to empower investors researching FUSN by allowing them to research the FUSN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree FUSN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Fusion Pharmaceuticals (FUSN) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

FUT Market Cap History
FVAM Market Cap History
FVC Market Cap History
FVIV Market Cap History
FVRR Market Cap History
FVT Market Cap History
FWAA Market Cap History
FWAC Market Cap History
FWP Market Cap History
FXCO Market Cap History
More Miscellaneous companies »

 

FUSN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.